pre-dispensed
Sponsors
Hospices Civils De Lyon, Fundacio Privada Mon Clinic Barcelona, Hospital General Universitario Gregorio Maranon
Conditions
AsthmaChronic Obstructive Pulmonary DiseaseChronic obstructive pulmonary diseases with Heart Failure with eyection ventricular ejection fraction between 35-50%
Phase 4
Symptoms control and adhErenCe assessment during treatment with mepolizUmab new pREfilled devices. SECURE
CompletedCTIS2022-501029-19-00
Start: 2022-12-13End: 2025-03-27Target: 130Updated: 2024-01-15
THE ANTES B+ STUDY: AN OPEN-LABEL, PRAGMATIC, RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPY VERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICAL CONTROL IN HIGH-RISK GOLD B PATIENTS (B+)
CompletedCTIS2023-507304-32-00
Start: 2024-02-09End: 2025-01-23Target: 1028Updated: 2024-04-04
Phase IV, single-center, double blind, randomized, crossover, placebo-controlled study, to investigate the effect of dual bronchodilation with umeclidinium/vilanterol on patients with COPD, hyperinflation and heart failure
Not yet recruitingCTIS2024-519513-61-00
Target: 60Updated: 2024-11-20